LET'S END

HEPC

Prevent. Treat. Cure. Together let’s END HepC!

Portugal

Elimination of HCV will not be achieved by 2030 with current policies (according to WHO elimination definition of HCV cut off of 90%).

Current Policies

National strategy that includes the HCV (clinical evaluation)  

Degree of implementation of the measure
  • Absence
  • Only for the prevention and diagnosis
  • Only for treatment
  • Presence both

National strategy that includes the HCV (evaluation of available resources)  

Degree of implementation of the measure
  • Absence
  • There are human and financial resources affects the strategy
  • There are monitoring strategies
  • presence both

National clinical guidelines for the diagnosis and treatment of HCV  

Degree of implementation of the measure
  • Absence
  • Only for diagnosis
  • Only for treatment
  • presence both

Involvement of civil society in defending the interests and rights of patients with HCV  

Degree of implementation of the measure
  • Do not exist
  • There are passively
  • Are actively

Events or awareness campaigns for HCV  

Degree of implementation of the measure
  • Never
  • Rarely
  • Sometimes
  • Often

National Register of disease for HCV  

Degree of implementation of the measure
  • Does not exist
  • Optional
  • Mandatory

legal framework particularly in terms of discrimination of patients with HCV  

Degree of implementation of the measure
  • Do not exist
  • There are only the labor framework
  • There are only in the framework of access to services and social facilities and public
  • Both

Involvement of primary health care  

Degree of implementation of the measure
  • Does not exist
  • Only in the prevention, screening and diagnosis of patients
  • Just following
  • Both

national policy to address the prevention of HCV infection  

Degree of implementation of the measure
  • Not Exists / Exists there but not adopted
  • Exists and is partially adopted
  • It exists and is fully adopted

Screening for HCV in blood donations  

Degree of implementation of the measure
  • No
  • Yes

Screening for HCV in tissue and organ donations  

Degree of implementation of the measure
  • They are not available
  • They are available but are not hindering donation
  • They are available and donation impeditive

Measures "safe health" - screening and treatment of surgical instruments, equipment and supplies  

Degree of implementation of the measure
  • Do not exist
  • There are methods of sterilization of materials
  • =+ There are certification methods - physical, chemical and biological indicators
  • Validation methods exist +

Risk reduction services available to the population of injecting drug users  

Degree of implementation of the measure
  • Do not exist
  • needle exchange program
  • opioid substitution program
  • There are both

Risk reduction services in prisons  

Degree of implementation of the measure
  • Do not exist
  • needle and syringe exchange program and / or safe consumption rooms effectively implemented
  • opioid substitution program
  • There are both

Test sites / screening HCV outside the hospital environment  

Degree of implementation of the measure
  • Absence
  • NGO
  • CSP
  • Presence of both

Screening in the general population  

Degree of implementation of the measure
  • Does not exist
  • Only the risk of ages
  • universal screening

Routine screening of HCV in pregnant  

Degree of implementation of the measure
  • Absence
  • Presence

Test the free and anonymous HCV targeted to groups with high prevalence  

Degree of implementation of the measure
  • They are not available
  • But are difficult to access
  • There are moderate access
  • They are widely available

Access for patients diagnosed with HCV to specialty consultations  

Degree of implementation of the measure
  • Do not exist
  • Exists with restrictions
  • There are no restrictions

Access to HCV staging monitoring  

Degree of implementation of the measure
  • Do not exist
  • Only during treatment
  • During treatment and after healing the sick

Availability of social support for patients with HCV  

Degree of implementation of the measure
  • Do not exist
  • Only support related to clinical issues
  • Support only related to non-clinical issues
  • Both

Access to treatment for HCV  

Degree of implementation of the measure
  • Just from stage F4
  • Only from stage F3
  • Just from stage F1-F2
  • In all stages

Types of drugs available for patients diagnosed with HCV (AAD vs. non-AAD)  

Degree of implementation of the measure
  • Just from stage F4
  • Only from stage F3
  • Just from stage F1-F2
  • In all stages

Evaluation of treatment outcomes  

Degree of implementation of the measure
  • Absence
  • Only the pre-AAD period
  • Only in the period AAD
  • Both


“Hepatitis C is found worldwide. The most affected regions are Africa and Central and East Asia. Depending on the country, hepatitis C infection can be concentrated in certain populations”

in WHO Fact sheet N°164
Updated July 2015